Literature DB >> 27504276

A Study of the Extended Lipid Profile including Oxidized LDL, Small Dense LDL, Lipoprotein (a) and Apolipoproteins in the Assessment of Cardiovascular Risk in Hypothyroid Patients.

Sanjiv Kumar Bansal1, Rakhee Yadav2.   

Abstract

INTRODUCTION: Hypothyroidism is one of the most common metabolic disorders associated with dyslipidemia which poses a higher risk of Coronary Artery Disease (CAD) in such patients. Biochemical markers which can pick up the risk promptly are becoming imperative now-a-days and thus the assessment beyond the conventional lipid profile is the need of the hour. AIMS: To assess the association of non-conventional lipid parameters like small dense Low Density Lipoprotein (sd LDL), oxidized Low Density Lipoprotein (ox LDL), Apolipoprotein A (Apo A1), Apolipoprotein B (Apo B) and Lipoprotein (a) {Lp(a)} in hypothyroid patients and compare their values with the conventional lipid parameters such as Total Cholesterol (TC), Triglyceride (TG), Low-Density Lipoprotein Cholesterol (LDL-C) and High-Density Lipoprotein Cholesterol (HDL-C).
MATERIALS AND METHODS: One hundred and thirty clinically proven patients of hypothyroidism aged 20-60 years and equal number of age and gender matched healthy individuals were included in this case control study. Serum sd LDL, ox LDL, Apo A1, Apo B, Lp (a), lipid profile, Thyroid Stimulating Hormone (TSH), Free Triiodothyronine (FT3) and Free Tetraiodothyronine (FT4) levels were measured in both the groups. The data was recorded and analysed on SPSS system. The results of cases and controls were compared by student t-test and one-way ANOVA. All the parameters were correlated with TSH by Pearson's correlation.
RESULTS: We found significantly high levels of sd LDL, ox LDL, Apo B, Lp (a), TC, TG, LDL-C in cases as compared to the controls. Ox LDL has shown maximum correlation with serum TSH (p<0.0001, r=0.801) followed by sd LDL (p<0.0001, r=0.792), Apo B (p<0.001, r=0.783) and LDL-C (p<0.001, r=0.741). Moreover, ox LDL and sd LDL were found to be increased in normolipidemic hypothyroid patients thereby giving a strong supportive evidence that estimation of these parameters can become fundamental in prompt identification of the high risk patients of CAD in hypothyroid population.
CONCLUSION: Non-conventional lipid parameters appear to be better markers for the assessment of cardiovascular risk in hypothyroidism and might help in the designing of the effective treatment protocols and areas of intervention by the clinicians as well as researchers.

Entities:  

Keywords:  Apolipoprotein A; Apolipoprotein B; Coronary artery disease; Hypothyroidism; oxidized; small dense Low Density Lipoprotein

Year:  2016        PMID: 27504276      PMCID: PMC4963636          DOI: 10.7860/JCDR/2016/19775.8067

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  33 in total

1.  Regulation of ATP-binding cassette transporter A1 transcription by thyroid hormone receptor.

Authors:  Jarkko Huuskonen; Meeta Vishnu; Clive R Pullinger; Phoebe E Fielding; Christopher J Fielding
Journal:  Biochemistry       Date:  2004-02-17       Impact factor: 3.162

Review 2.  Small dense LDL: risk factor for coronary artery disease (CAD) and its therapeutic modulation.

Authors:  Suman B Sharma; Seema Garg
Journal:  Indian J Biochem Biophys       Date:  2012-04       Impact factor: 1.918

Review 3.  Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation.

Authors:  John D Brunzell; Michael Davidson; Curt D Furberg; Ronald B Goldberg; Barbara V Howard; James H Stein; Joseph L Witztum
Journal:  J Am Coll Cardiol       Date:  2008-04-15       Impact factor: 24.094

Review 4.  Protein sensors for membrane sterols.

Authors:  Joseph L Goldstein; Russell A DeBose-Boyd; Michael S Brown
Journal:  Cell       Date:  2006-01-13       Impact factor: 41.582

Review 5.  Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy.

Authors:  Sona Mitra; Abhishek Deshmukh; Rajesh Sachdeva; Jingjun Lu; Jawahar L Mehta
Journal:  Am J Med Sci       Date:  2011-08       Impact factor: 2.378

6.  Relationship of low-density lipoprotein (LDL) particle size to thyroid function status in Koreans.

Authors:  Chul Sik Kim; Jun Goo Kang; Seong Jin Lee; Sung Hee Ihm; Hyung Joon Yoo; Ji Sun Nam; Chul Woo Ahn; Kyung Rae Kim
Journal:  Clin Endocrinol (Oxf)       Date:  2008-09-28       Impact factor: 3.478

7.  Activation of the hepatic LDL receptor promoter by thyroid hormone.

Authors:  Dayami Lopez; Jose F Abisambra Socarrás; Mohini Bedi; Gene C Ness
Journal:  Biochim Biophys Acta       Date:  2007-05-21

Review 8.  APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency.

Authors:  Sebastiano Calandra; Claudio Priore Oliva; Patrizia Tarugi; Stefano Bertolini
Journal:  Curr Opin Lipidol       Date:  2006-04       Impact factor: 4.776

Review 9.  Lipoprotein(a), cardiovascular disease, and contemporary management.

Authors:  Terry A Jacobson
Journal:  Mayo Clin Proc       Date:  2013-11       Impact factor: 7.616

10.  Predictors of outcome in myxoedema coma: a study from a tertiary care centre.

Authors:  Pinaki Dutta; Anil Bhansali; Shriq Rashid Masoodi; Sanjay Bhadada; Navneet Sharma; Rajesh Rajput
Journal:  Crit Care       Date:  2008-01-03       Impact factor: 9.097

View more
  5 in total

Review 1.  Atherosclerosis Development and Progression: The Role of Atherogenic Small, Dense LDL.

Authors:  Jelena Vekic; Aleksandra Zeljkovic; Arrigo F G Cicero; Andrej Janez; Anca Pantea Stoian; Alper Sonmez; Manfredi Rizzo
Journal:  Medicina (Kaunas)       Date:  2022-02-16       Impact factor: 2.430

Review 2.  Hashimoto Thyroiditis and Dyslipidemia in Childhood: A Review.

Authors:  Rade Vukovic; Aleksandra Zeljkovic; Biljana Bufan; Vesna Spasojevic-Kalimanovska; Tatjana Milenkovic; Jelena Vekic
Journal:  Front Endocrinol (Lausanne)       Date:  2019-12-10       Impact factor: 5.555

Review 3.  Small, Dense Low-Density Lipoprotein-Cholesterol and Atherosclerosis: Relationship and Therapeutic Strategies.

Authors:  Xiao Jin; Shengjie Yang; Jing Lu; Min Wu
Journal:  Front Cardiovasc Med       Date:  2022-02-10

Review 4.  Non-genetic influences on lipoprotein(a) concentrations.

Authors:  Byambaa Enkhmaa; Lars Berglund
Journal:  Atherosclerosis       Date:  2022-05       Impact factor: 6.847

5.  Impact of small and dense low-density lipoprotein (sd-LDL)on contrast-induced acute kidney injury in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Authors:  Yuhan Li; Kai Ma; Guoqi Shen; Di Zheng; Yongli Xuan; Wenhua Li
Journal:  Int Urol Nephrol       Date:  2021-03-06       Impact factor: 2.370

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.